Synopsis of recent research by authors named "Sara Sarwar"
- Recent research by Sara Sarwar focuses on the application and implications of chimeric antigen receptor (CAR) T-cell therapy within the field of ophthalmology, specifically addressing its use in treating ocular tumors like retinoblastoma and uveal melanoma.
- In her article published in July 2024, Sarwar conducts a narrative review highlighting the adverse events associated with CAR T-cell therapy, emphasizing the importance of understanding these risks for better clinical outcomes.
- The research underscores the significance of CAR T-cell therapy as a groundbreaking advancement in immunotherapy while calling attention to the potential complications that may arise during treatment, enhancing the discourse on safety in novel therapeutic approaches.
